Skip to content
Back to glossary
Biomarkers

ApoA-I (Apolipoprotein A-I)

Apolipoprotein A-I (ApoA-I) is the main protein of 'good' HDL cholesterol. Your liver and gut make it, and it makes up about 70% of HDL's protein. It switches on an enzyme (LCAT) that drives 'reverse cholesterol transport', carrying cholesterol from your tissues back to the liver. Labs measure it by immunoassay, calibrated to a WHO/IFCC standard. Typical ranges are 110 to 180 mg/dL in men and 120 to 200 in women. It shines in one big study. In INTERHEART (12,461 cases and 14,637 controls across 52 countries), the ApoB/ApoA-I ratio was the single strongest lipid predictor of a first heart attack (odds ratio about 3.25, top vs bottom fifth). That beat the usual LDL-C/HDL-C ratio. Watch the confounders, though. Infection and inflammation drop it 20 to 30%. Pregnancy and oral estrogen raise it. Severe liver disease and rare ApoA-I mutations (Tangier disease, ApoA-I Milano) also shift it.

Last reviewed:

This definition is educational and is not medical advice, a diagnosis, or treatment. Talk to a doctor about any health decisions. Read our full medical disclaimer

Sources

  1. McQueen MJ, Hawken S, Wang X, et al.. (2008). Lipids, lipoproteins, and apolipoproteins as risk markers of myocardial infarction in 52 countries (the INTERHEART study): a case-control study. *Lancet*doi:10.1016/S0140-6736(08)61076-4
  2. Walldius G, Jungner I. (2004). Apolipoprotein B and apolipoprotein A-I: risk indicators of coronary heart disease and targets for lipid-modifying therapy. *Journal of Internal Medicine*doi:10.1111/j.1365-2796.2004.01345.x